Amigenics

Amigenics is a biotechnology company developing therapeutic proteins for oncology, infectious diseases, and autoimmune disorders. Amigenics' proprietary technology generates therapeutic proteins with human-like glycosylation, enabling well-tolerated products with longer half-lives and enhanced clinical efficacy. Using this technology, the company has demonstrated the ability to achieve commercially viable levels of therapeutic protein production and purification.